EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar

Dalal Al-Sharshani, Dinesh Velayutham, Muthanna Samara, Reham Gazal, Ayman Al Haj Zen, Mohamed A Ismail, Mahmoud Ahmed, Gheyath Nasrallah, Salma Younes, Nasser Rizk, Sara Hammuda, M Walid Qoronfleh und 11 weitere

Molecular Genetics & Genomic Medicine · 2023-08 · 11 (8)

DOI: 10.1002/mgg3.2178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 05.05.2023. Verfasst von Dalal Al-Sharshani und 22 weiteren Autor:innen. Beteiligte Einrichtung: Heart Hospital (HH), Hamad Medical Corporation (HMC), Doha, Qatar. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, Hypertension, Cardiovascular Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dyslipidemia is recognized as one of the risk factors of cardiovascular diseases (CVDs), type 2 diabetes mellitus (T2DM), and non‐alcoholic fatty liver disease (NAFLD).

Objective

The study aimed to investigate the association between selected single nucleotide polymorphisms (SNPs) with dyslipidemia and increased susceptibility risks of CVD, NAFLD, and/or T2DM in dyslipidemia patients in comparison with healthy control individuals from the Qatar genome project.

Methods

A community‐based cross‐sectional study was conducted among 2933 adults (859 dyslipidemia patients and 2074 healthy control individuals) from April to December 2021 to investigate the association between 331 selected SNPs with dyslipidemia and increased susceptibility risks of CVD, NAFLD and/or T2DM, and covariates.

Results

The genotypic frequencies of six SNPs were found to be significantly different in dyslipidemia patients subjects compared to the control group among males and females. In males, three SNPs were found to be significant, the rs11172113 in over‐dominant model, the rs646776 in recessive and over‐dominant models, and the rs1111875 in dominant model. On the other hand, two SNPs were found to be significant in females, including rs2954029 in recessive model, and rs1801251 in dominant and recessive models. The rs17514846 SNP was found for dominant and over‐dominant models among males and only the dominant model for females. We found that the six SNPs linked to gender type had an influence in relation to disease susceptibility. When controlling for the four covariates (gender, obesity, hypertension, and diabetes), the difference between dyslipidemia and the control group remained significant for the six variants. Finally, males were three times more likely to have dyslipidemia in comparison with females, hypertension was two times more likely to be present in the dyslipidemia group, and diabetes was six times more likely to be in the dyslipidemia group.

Conclusion

The current investigation provides evidence of association for a common SNP to coronary heart disease and suggests a sex‐dependent effect and encourage potential therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseHypertensionCardiovascular DiseasesDyslipidemiasAdultMaleFemaleHumansPolymorphism, Single NucleotideQatarCross-Sectional Studies

Stichwörter der Autor:innen

Qatar genome project (QGP)cardiovascular disease (CVD)coronary artery disease (CAD)diabetesdyslipidemiahypertensionmetabolicnon-alcoholic fatty liver disease (NAFLD)single nucleotide polymorphism (SNP)

Autor:innen und Institutionen

  • Heart Hospital (HH), Hamad Medical Corporation (HMC), Doha, Qatar.
  • Genomics and Precision Medicine (GPM), College of Health & Life Science (CHLS), Hamad Bin Khalifa University (HBKU), Doha, Qatar.
  • Liberal Arts and Science (LAS), Hamad Bin Khalifa University (HBKU), Doha, Qatar.
  • Department of Psychology, Kingston University London, Kingston upon Thames, London, UK.
  • Department of Research, Women's Wellness and Research Center (WWRC), Hamad Medical Corporation (HMC), Doha, Qatar.
  • College of Health & Life Science (CHLS), Hamad Bin Khalifa University (HBKU), Doha, Qatar.

ORCID-Profile: Ahmed Mahfouz, Nader I Al-Dewik

Zitieren

APA

Al-Sharshani, D., Velayutham, D., Samara, M., Gazal, R., Al Haj Zen, A., Ismail, M. A., Ahmed, M., Nasrallah, G., Younes, S., Rizk, N., Hammuda, S., Qoronfleh, M. W., Farrell, T., Zayed, H., Abdulrouf, P. V., AlDweik, M., Silang, J. P. B., Rahhal, A., Al-Jurf, R., …, & Al-Dewik, N. I. (2023). Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar. Molecular Genetics & Genomic Medicine, 11(8). https://doi.org/10.1002/mgg3.2178

Vancouver

Al-Sharshani D, Velayutham D, Samara M, Gazal R, Al Haj Zen A, Ismail MA, et al. Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar. Molecular Genetics & Genomic Medicine. 2023;11(8). doi:10.1002/mgg3.2178

BibTeX
@article{AlSharshani2023,
  author = {Al-Sharshani, Dalal and Velayutham, Dinesh and Samara, Muthanna and Gazal, Reham and Al Haj Zen, Ayman and Ismail, Mohamed A and Ahmed, Mahmoud and Nasrallah, Gheyath and Younes, Salma and Rizk, Nasser and Hammuda, Sara and Qoronfleh, M Walid and Farrell, Thomas and Zayed, Hatem and Abdulrouf, Palli Valapila and AlDweik, Manar and Silang, John Paul Ben and Rahhal, Alaa and Al-Jurf, Rana and Mahfouz, Ahmed and Salam, Amar and Al Rifai, Hilal and Al-Dewik, Nader I},
  title = {Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2023},
  volume = {11},
  number = {8},
  doi = {10.1002/mgg3.2178}
}
Kostenlos starten →